Skip to content
healthcare.dev

up and up mint mini nicotine

NDC 82442-734, Nicotine Polacrilex, lozenge, from Target Corporation.

Product NDC
82442-734
Status
Listed
Labeler
Target Corporation
Dosage form
LOZENGE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA203690
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82442-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NICOTINE2 mg/1

Pharmacologic classes

Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]

Package NDCNDC-11Package
82442-734-02824420734023 CONTAINER in 1 CARTON (82442-734-02) / 27 LOZENGE in 1 CONTAINER (82442-734-01)
82442-734-03824420734034 CONTAINER in 1 CARTON (82442-734-03) / 27 LOZENGE in 1 CONTAINER (82442-734-01)
82442-734-60824420734601 CONTAINER in 1 CARTON (82442-734-60) / 20 LOZENGE in 1 CONTAINER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82442-734 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82442-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82442-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.